Scleral Window Surgery with Mitomycin C for Nanophthalmic Uveal Effusion: Case Report. |
Seong Jae Kim, Gyu Nam Kim, Yong Seop Han, In Young Chung, Seong Wook Seo, Ji Myong Yoo, Jong Moon Park |
1Department of Ophthalmology, Gyeongsang National University School of Medicine, Jinju, Korea. parkjm@gnu.ac.kr 2Gyeongsang Institute of Health Science, Gyeongsang National University, Jinju, Korea. |
마이토마이신 씨를 이용한 공막절개술로 치료한 단순소안구성포도막삼출 1예 |
김성재1,2⋅김규남1⋅한용섭1,2⋅정인영1,2⋅서성욱1,2⋅유지명1,2⋅박종문1,2 |
Department of Ophthalmology, Gyeongsang National University School of Medicine1, Jinju, Korea Gyeongsang Institute of Health Science, Gyeongsang National University2, Jinju, Korea |
|
Abstract |
PURPOSE To report the case of a 36-year-old patient with nanophthalmic uveal effusion was treated with scleral window surgery and topical administration of mitomycin C (MMC). CASE SUMMARY: A 36-year-old woman presented with decreased visual acuity and blurred vision in the both eyes during 3 months. Fundus examination revealed choroidal effusion and retinal detachment with thickend sclera wall and short axial lengh. Partial-thickness sclera flap with deep sclerostomy was performed and topical MMC was administered to one quadrant of the equatorial sclera. The subretinal fluid resorbed gradually and visual acuity improved. CONCLUSIONS: Scleral window surgery and topical mitomycin C might relieve the blocked transscleral outflow of intraocular fluid in the small area of a sclerostomy in young patient with nanophthlamos. |
Key Words:
Mitomycin C;Nanophthalmos;Scleral window surgery;Uveal effusion syndrome |
|